Incyte Corp (INCY)
56.95
-0.17
(-0.30%)
USD |
NASDAQ |
Mar 28, 16:00
56.97
+0.02
(+0.04%)
Pre-Market: 20:00
Incyte Total Liabilities (Quarterly): 1.592B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.592B |
September 30, 2023 | 1.457B |
June 30, 2023 | 1.468B |
March 31, 2023 | 1.335B |
December 31, 2022 | 1.471B |
September 30, 2022 | 1.284B |
June 30, 2022 | 1.234B |
March 31, 2022 | 1.191B |
December 31, 2021 | 1.163B |
September 30, 2021 | 1.050B |
June 30, 2021 | 968.76M |
March 31, 2021 | 933.59M |
December 31, 2020 | 949.65M |
September 30, 2020 | 916.60M |
June 30, 2020 | 867.72M |
March 31, 2020 | 814.70M |
December 31, 2019 | 828.34M |
September 30, 2019 | 792.29M |
June 30, 2019 | 700.44M |
March 31, 2019 | 668.59M |
December 31, 2018 | 719.80M |
September 30, 2018 | 717.05M |
June 30, 2018 | 664.23M |
March 31, 2018 | 677.97M |
December 31, 2017 | 671.95M |
Date | Value |
---|---|
September 30, 2017 | 616.55M |
June 30, 2017 | 612.61M |
March 31, 2017 | 641.41M |
December 31, 2016 | 1.219B |
September 30, 2016 | 1.174B |
June 30, 2016 | 1.121B |
March 31, 2016 | 876.19M |
December 31, 2015 | 836.28M |
September 30, 2015 | 843.20M |
June 30, 2015 | 875.16M |
March 31, 2015 | 904.04M |
December 31, 2014 | 878.10M |
September 30, 2014 | 874.86M |
June 30, 2014 | 850.10M |
March 31, 2014 | 829.25M |
December 31, 2013 | 822.68M |
September 30, 2013 | 328.61M |
June 30, 2013 | 362.00M |
March 31, 2013 | 493.81M |
December 31, 2012 | 505.38M |
September 30, 2012 | 516.48M |
June 30, 2012 | 529.16M |
March 31, 2012 | 542.45M |
December 31, 2011 | 556.04M |
September 30, 2011 | 552.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
668.59M
Minimum
Mar 2019
1.592B
Maximum
Dec 2023
1.084B
Average
1.009B
Median
Total Liabilities (Quarterly) Benchmarks
Novartis AG | 53.20B |
MorphoSys AG | 2.186B |
Biogen Inc | 12.05B |
Illumina Inc | 4.366B |
Johnson & Johnson | 98.78B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.782B |
Shareholders Equity (Quarterly) | 5.190B |
Current Ratio | 3.745 |